Cardiovascular outcomes in trials of oral diabetes medications: a systematic review - sprookjes - yvandenbroek - TriplyDB

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

http://www.wikidata.org/entity/Q22253058

about

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults Sulphonylurea monotherapy for patients with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus Non-incretin insulin secretagogues for patients with type 2 diabetes mellitus Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement What's next after metformin? focus on sulphonylurea: add-on or combination therapy Cellular and molecular mechanisms of metformin: an overview Diabetes mellitus and cognitive impairments Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials Effects of AMP-activated protein kinase in cerebral ischemia Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review.Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.Leptin revisited: its mechanism of action and potential for treating diabetes.Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.Hypoglycemic and anti-depressant effects of Zuogui Jiangtang Jieyu formulation in a model of unpredictable chronic mild stress in rats with diabetes mellitus.Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study.Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.Differing effects of metformin on glycemic control by race-ethnicity.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.Therapy for Alzheimer's Disease: How Effective are Current Treatments?Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study Diabetes treatment and cardiovascular safety Diabetes: glycaemic control in type 2 (drug treatments).Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis The relationship between glycated hemoglobin and complexity of coronary artery lesions among older patients with diabetes mellitus.Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study.Treating coronary disease and the impact of endothelial dysfunction.Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis Metformin in patients with type 2 diabetes and kidney disease: a systematic review.Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs.

P2860

Q21144611-006F2472-8EBE-4365-95BA-77EC7EB7659B Q22241134-27583045-D5BE-405B-883C-59C74734B098 Q22250879-2B83CF22-47AA-489D-B502-A06BFD424003 Q24186660-267C7FEB-5FA2-45A4-8E29-18D94CCF2849 Q24197884-C6DB4B5C-4340-4DDA-A6A1-9AB34613CE33 Q24234574-279F3200-DED4-4415-BE3E-B3C62C84E063 Q24628988-C482F9BA-4241-4611-A2A7-D29060C262EF Q26783199-8A232FEA-21C8-4DF2-BDD0-EA933D479F2E Q26786524-F7BFC8DF-D14B-4365-A890-903365CCA4BF Q27013561-CA4729A7-5A4A-4B26-A518-F0E819D931B3 Q28079459-7410651C-1DB8-4017-9BC8-142A43321522 Q28256514-2E2465DF-839D-4FB1-ABE3-5E977D4E22CF Q28394686-325EC575-D0CA-4971-8EFA-9CF0D50FD456 Q28533840-36825B35-3D7D-451C-B5FA-FBE237A668D0 Q29038351-6C5FA8F9-C7F0-4F7D-80CD-DD645C5D89C1 Q30241808-9B8183A0-13DD-4795-A250-45BD983382F1 Q31143283-F6A2B5FC-E397-4658-880E-E6718F09E207 Q33602487-29594343-1F27-4985-9D3F-4C0572B331F5 Q33754815-478A263B-3526-47C7-BA85-07FF6C60FC7D Q33769594-96B2A261-E733-4F2C-95B5-25818F62A3F0 Q33785313-5CC040A8-B41C-4B1A-BC7A-BA916C46061B Q33817568-E30CA7B9-3824-45FC-8EBA-4D1CAE9DA0A5 Q33873040-EADA1637-B233-4906-BD88-B8813FA8D877 Q34024341-63283326-44D2-45F2-925B-B10CB5FC1B19 Q34129085-102DFD2D-C620-48D4-98EC-CB38835D191D Q34130997-D1F8C6C1-744F-4C8C-BBEA-43238EF62106 Q34135248-EDB2D003-899B-4935-A617-E6291EE53D95 Q34345083-0AA640DF-B132-4E78-90BB-E31E471B2BC8 Q34409349-967E5DA3-ACD2-489B-9E95-17E209D23D5C Q34644993-85448D0D-96E6-48A3-B8D1-BC51D6A17013 Q34718512-391E14D4-131F-42DF-88AD-2F7A1AF60EF7 Q34829290-C468E2EE-52DB-4FCC-8DFB-0EACA9A574FF Q35044151-9FCFFC28-CB2B-449E-A52A-CAEF6A17C1AB Q35114963-3971372A-6EAC-48E9-956F-8255AA73E949 Q35127858-E30AD9FC-118F-44D9-939E-EBB8AA0F698F Q35155185-7E34DE15-1C85-4FE1-B968-C347BB48FBC9 Q35196366-A734E0C8-72E0-4CA1-841D-D07B7A02C4F1 Q35399258-277F8E09-2ED5-41AB-861E-9CAF8C39A6A6 Q35533239-2D40F1B9-58CA-43F5-8924-80905D0B7B0D Q35535310-D30D6042-F999-418B-A525-D7480BE22CB2

P2860

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

http://www.wikidata.org/entity/Q22253058

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@ast

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en-gb

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@nl

type

label

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@ast

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en-gb

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@nl

prefLabel

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@ast

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en-gb

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@nl

P1433

Q22253058-519B6EA5-315F-489F-BB48-AD8A8811B247

P1476

Q22253058-AEC20840-3BF9-4576-A8B1-1B5D62F3F444

P2093

Q22253058-0C80E8D4-739E-4252-8137-45BDA3E4E9B3

Q22253058-30CCB7F8-A8AC-416A-B9AD-7B3408954A34

Q22253058-46A417CF-B9D4-477D-A3A7-603028E72298

Q22253058-5D2DFFCC-9874-43FE-9656-2CEC5DC2DA1C

Q22253058-694F060D-6213-4E8B-8DC5-0E9A939EA15B

Q22253058-699C2493-0C75-4B50-AB3F-ED7B8E8908F2

Q22253058-B3C595FD-6B8D-43DE-849C-957806CFA98C

Q22253058-B91C73B2-627F-41EF-B31E-BA06BB7A4758

Q22253058-E073F398-71C2-4A35-B663-8BE262880C2A

P2860

Q22253058-0914AAAC-CC59-457C-83A8-738B5EEB9F4C

Q22253058-0B91784D-8F9D-4E1E-A4AE-AD0F17C011C6

Q22253058-1CF8F1EC-8212-4ACE-9A3A-437D30E4BE02

Q22253058-231B4A0F-3631-4A94-8A95-47C0205CCD9B

Q22253058-23477D66-2FC4-4654-8126-4D8E926CA3D8

Q22253058-259179D4-04E9-481A-8813-AC581058F9B1

Q22253058-26688575-9133-4655-B48B-53F3B0B70468

Q22253058-2C9F5C79-B181-4306-BCF6-36D21E720995

Q22253058-31D2452F-BAC4-4E4C-8077-50F6E667356A

Q22253058-335FC8F1-74EC-46C9-AA22-77358E34351F

P304

Q22253058-527E0FE7-D796-40ED-8720-3691293E8D73

P31

Q22253058-24C730DD-1ABE-4A71-BEAE-2D8B411EAED5

Q22253058-6521325D-974B-4EEF-85E3-70561AAD894F

P356

Q22253058-2613DD35-8830-4633-A2DA-42B72DA4463D

P407

Q22253058-E18C6C80-0251-40B1-A9DF-71892C1757A9

P433

Q22253058-56376F06-E298-446F-AE4C-9062898C625B

P478

Q22253058-1FECE967-71F5-45B0-B509-6E2B4D81A762

P50

Q22253058-0CE14C68-7236-4D84-BF95-C3CDD77F0FFC

Q22253058-DC7825C1-ED6E-4D1D-92F6-B4B6F9A9FFE2

P577

Q22253058-FB7306A0-CC56-4D7C-A1A4-B11B05FF9AA4

P5875

Q22253058-ACEBF477-B337-4220-B6B2-74F16FD38772

P698

Q22253058-AC0168C1-1E4B-4CEE-A0E2-D7D3CF89F4BC

P921

Q22253058-5C132C1B-0315-4520-8200-AEDAC644D94B

P932

Q22253058-ED179ABB-BB7A-4A6D-8D6D-1327AD1192E2

P356

ARCHINTE.168.19.2070

P1433

JAMA Internal Medicine

P1476

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

@en

P2093

Crystal Wiley

http://www.w3.org/2001/XMLSchema#string

Elizabeth Selvin

http://www.w3.org/2001/XMLSchema#string

Eric B Bass

http://www.w3.org/2001/XMLSchema#string

Frederick L Brancati

http://www.w3.org/2001/XMLSchema#string

Hsin-Chieh Yeh

http://www.w3.org/2001/XMLSchema#string

Lisa M Wilson

http://www.w3.org/2001/XMLSchema#string

Renee Wilson

http://www.w3.org/2001/XMLSchema#string

Shari Bolen

http://www.w3.org/2001/XMLSchema#string

Spyridon S Marinopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Rosiglitazone for type 2 diabetes mellitus

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Measuring inconsistency in meta-analyses

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Statistical aspects of the analysis of data from retrospective studies of disease

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

P304

2070-2080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1001/ARCHINTE.168.19.2070

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Leonard S. Feldman

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23423415

http://www.w3.org/2001/XMLSchema#string

P698

18955635

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2765722

http://www.w3.org/2001/XMLSchema#string